blue & yellow antibodiesPublished October 5, 2021 at dimensions 620 × 480 in ACTG Announces Graduation of Novel Polyclonal Antibody Therapy SAB-185 to Phase 3 Study in ACTIV-2. https://www.clevelandhiv.org/wp-content/uploads/2021/10/blue-yellow-antibodies.jpeg